Everolimus Teva 10 mg Tablets
- Licence status
- Withdrawn: 17/03/2020
- Active substances
- Everolimus
- Dosage Form
- Tablet
- Licence number
- PA1986/034/003
- Licence holder
- Teva B.V.
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01XE Protein kinase inhibitors, L01XE01 imatinib
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 30/06/2017